• Mutation; HGNC; 9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
  
• Mutation; HGNC; 9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
  

PubMed=16170671; DOI=10.1007/s10585-005-0745-1
Vantyghem S.A., Allan A.L., Postenka C.O., Al-Katib W., Keeney M., Tuck A.B., Chambers A.F.
A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.
Clin. Exp. Metastasis 22:351-361(2005)

PubMed=18262045; DOI=10.1016/j.cancergencyto.2007.05.030
Xu J., Chambers A.F., Tuck A.B., Rodenhiser D.I.
Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
Cancer Genet. Cytogenet. 181:1-7(2008)

PubMed=20084286; DOI=10.1371/journal.pone.0008665; PMCID=PMC2801616
Andrews J.D., Kennette W., Pilon J., Hodgson A., Tuck A.B., Chambers A.F., Rodenhiser D.I.
Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
PLoS ONE 5:E8665-E8665(2010)